Navigation Links
Sanofi Pasteur Announces Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Infants and Children
Date:10/14/2009

eported have been similar to those observed with the seasonal influenza vaccine.

About Influenza A (H1N1) 2009 Monovalent Vaccine

The U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine manufactured by Sanofi Pasteur is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza disease caused by pandemic (H1N1) 2009 virus. Influenza A (H1N1) 2009 Monovalent Vaccine was licensed by the U.S. Food and Drug Administration on September 15 as a monovalent strain change to Sanofi Pasteur's licensed seasonal influenza vaccine.

The Influenza A (H1N1) 2009 Monovalent Vaccine is manufactured by the same process as Sanofi Pasteur's seasonal trivalent influenza virus vaccine licensed in the U.S. Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg hemagglutinin (HA) of influenza A/California/07/2009 (H1N1) v-like virus. Influenza A (H1N1) 2009 Monovalent Vaccine is licensed for single-dose presentations in syringes and vials and in multi-dose vials. There is no preservative used in the single-dose presentations. Multi-dose vials contain a preservative.

Safety Information for Influenza A (H1N1) 2009 Monovalent Vaccine

Influenza vaccine should not be administered to anyone with a known severe hypersensitivity to egg proteins, any vaccine component or life-threatening reactions after previous administration of any influenza vaccine. Recurrence of Guillain-Barre syndrome (GBS) has been temporally associated with the administration of influenza vaccine. The decision to give Influenza A (H1N1) 2009 Monovalent Vaccine to individuals who have a prior history of GBS should be based on careful consideration of the potential benefits and risks. Vaccination with Influenza A (H1N1) 2009 Monovalent Vaccine may not protect all individuals.

Before administering Influenza A (H1N1) 2009 Monovalent Vaccine, p
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
10. Sanofi-aventis Stands Behind the Safety of Lantus(R)
11. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014   Ventana Medical ...  Group, today announced that its VENTANA System for ... in the European Union for routine pathology, including ... consisting of VENTANA Virtuoso software coupled with either ... HT slide scanner, provides automated digital slide creation, ...
(Date:8/20/2014)... Mass. , Aug. 20, 2014 /PRNewswire/ ... electrophysiology (EP) mapping and ablation device market ... use ablation to treat atrial fibrillation (AF). ... primary treatment option for AF will spur ... this application, such as advanced loop diagnostic ...
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. ... Co. Ltd., has received Chinese FDA (CFDA) approval ... mg Tablets into the China ... marketing and distribution agreement with Sinochem Jiangsu Pharmaceutical ... its US FDA approved and China CFDA certified ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2
... South Korea, Feb. 25 Dong-A PharmTech Co., ... Pharma, has initiated,a 200 patient, phase 2 proof ... udenafil, a long acting phosphodiesterase type 5 inhibitor, ... European,study is designed to investigate the safety and ...
... Enterprise Intelligence Systems to Healthcare Market, ... #1841 --,Harris Corporation (NYSE: HRS ), ... joined forces with Cancer Treatment,Services International (CTSI) ... oncology. Harris will provide advanced imaging and ...
Cached Medicine Technology:Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil 2Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil 3Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment 2
(Date:8/20/2014)... August 20, 2014 Biocide Systems ... on Wrench Advisors as a consultant and partner ... large accounts. , As Wrench Advisors explains on ... help your organization plan and execute programs by ... distribution channels. Our experience developing joint venture partnerships ...
(Date:8/20/2014)... TX (PRWEB) August 20, 2014 The ... Surgery (ACPS), has expanded its presence throughout Houston to ... Mann Eye Institute and Laser Center building. ACPS plastic ... natural step forward for ACPS, which has risen to ... plastic surgery practices in the state since its establishment ...
(Date:8/20/2014)... Aug. 20, 2014 (HealthDay News) -- White, straight women ... than minority, bisexual or lesbian women, a new study ... American women, aged 21 to 44, who took part ... of the National Survey of Family Growth study. ... women said they sought treatment for infertility. This ranged ...
(Date:8/20/2014)... receiving mental health services from the Veterans Health Administration ... among all areas studied. , The RAND Corporation study, ... a substance use disorder were less satisfied than other ... abuse problems also were less likely than others to ... decisions. , The findings, published in the journal ...
(Date:8/20/2014)... predict both breast cancer relapses and responses to ... The newly found marker could help doctors classify ... regimen that is more effective. The discovery was ... of Molecular and Cell Biology (IMCB), and the ... the National University of Singapore (NUS). , Despite ...
Breaking Medicine News(10 mins):Health News:Biocide Systems Announces Partnership with Wrench Advisors 2Health News:Aesthetic Center for Plastic Surgery Expands Its Reach in Texas 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2Health News:Survey finds veterans generally satisfied with mental health care 2Health News:Novel gene predicts both breast cancer relapse and response to chemotherapy 2
... of winning a battle with cancer, as opposed to adults, ... years ago.// A recent report has explained that despite ... absolve them from the risks of long-term health problems in ... Childhood Cancer Survivor Study is a long-standing pioneer in the ...
... patients with severe psoriasis, appear to be at increased ... in the October 11 issue of JAMA.// ,Psoriasis ... percent to 3 percent of the adult population. It ... increased C-reactive protein levels, which have been linked to ...
... Kankova and colleagues from the Departments of Parasitology, Microbiology ... and GynCentrum, in the Czech Republic, women with dormant ... who are Toxoplasma negative. // ,Toxoplasma gondii ... with a universal occurrence of 20-80%. This study is ...
... for answers, but when it comes to cancer, physicians ... cancers. While certain tests can indicate the possibility of ... to monitor patients for cancer currently is not available ... University of Virginia School of Medicine are out to ...
... Parents with allergic symptoms like wheezing, asthma, hay ... to their infants too, according to a study by ... practice of avoiding skin testing for airborne allergens before ... in this high-risk group can be detected early and ...
... dengue death was reported in the capital, taking the toll ... city hospitals.// ,The total number of dengue cases in ... victim of the mosquito-borne viral disease was 25-year-old Farahan of ... Medical Science (AIIMS) here Friday and died in the early ...
Cached Medicine News:Health News:Childhood Cancer Survivors May Suffer Health Problems in Adulthood 2Health News:Psoriasis Associated With Increased Risk For Heart Attack 2Health News:Effect of parasitic infection on baby's sex 2Health News:Researchers Developing Office-Based Cancer Screening Test 2Health News:Allergy Sufferers Pass on Allergies to their Children 2Health News:Dengue Claims Yet Another Victim in Delhi 2
Manual Lensmeter....
Lightweight, cordless lensmeter....
Lightweight, cordless lensmeter....
... 101 is well suited for measuring ... well as conventional spectacle lenses. It ... a full 90-degree inclination, which facilitates ... used in the vertical position. The ...
Medicine Products: